Activation of innate immune defense mechanisms by signaling through RIG-I/IPS-1 in intestinal epithelial cells.
Intestinal epithelial cells (IECs) are a first line of defense against microbial pathogens that enter the host through the intestinal tract. Moreover, viral pathogens that infect the host via the intestinal epithelium are an important cause of morbidity and mortality. However, the mechanisms by which viral pathogens activate antiviral defense mechanisms in IECs are largely unknown. The synthetic dsRNA analog polyinosinic-polycytidylic acid and infection with live virus were used to probe the molecules that are activated and the mechanisms of signaling in virus-infected human IECs. Polyinosinic-polycytidylic acid activated IFN regulatory factor 3 dimerization and phosphorylation, increased activity of the IFN-stimulated response element, induced a significant increase in IFN-beta mRNA transcripts and IFN-beta secretion, and up-regulated the expression of IFN-regulated genes in IECs. Those responses were dependent upon activation of the dsRNA binding protein retinoic acid inducible gene I (RIG-I) and the RIG-I interacting protein IFN promoter stimulator-1, but not on dsRNA-activated protein kinase or TLR3, which also were expressed by IECs. Virus replication and virus-induced cell death increased in IECs in which RIG-I was silenced, consistent with the importance of the RIG-I signaling pathway in IEC antiviral innate immune defense mechanisms.
Hirata
Yoshihiro
Y
Department of Medicine, University of California at San Diego, La Jolla, CA 92093, USA.
Broquet
Alexis H
AH
Menchén
Luis
L
Kagnoff
Martin F
MF
D048868:Adaptor Proteins, Signal Transducing / Q000502:physiology*; D002478:Cells, Cultured; D019073:HT29 Cells; D006801:Humans; D007113:Immunity, Innate; D050838:Interferon Regulatory Factor-3 / Q000378:metabolism; D007370:Interferon Type I / Q000096:biosynthesis / Q000378:metabolism; D016899:Interferon-beta / Q000378:metabolism; D007413:Intestinal Mucosa / Q000166:cytology / Q000276:immunology* / Q000378:metabolism*; D011070:Poly I-C / Q000494:pharmacology; D018168:Receptors, Retinoic Acid / Q000502:physiology*; D020218:Response Elements; D015398:Signal Transduction / Q000276:immunology*; D015854:Up-Regulation / Q000276:immunology; D014721:Vesicular stomatitis Indiana virus / Q000276:immunology
D048868:Adaptor Proteins, Signal Transducing; D050838:Interferon Regulatory Factor-3; D007370:Interferon Type I; C505371:MAVS protein, human; C437968:PLAAT4 protein, human; D018168:Receptors, Retinoic Acid; D016899:Interferon-beta; D011070:Poly I-C